uniQure N.V. (QURE)
NASDAQ: QURE · Real-Time Price · USD
38.97
-0.46 (-1.17%)
At close: Jul 24, 2026, 4:00 PM EDT
38.75
-0.22 (-0.56%)
After-hours: Jul 24, 2026, 7:52 PM EDT
uniQure Market Cap
uniQure has a market cap or net worth of $2.68 billion as of July 24, 2026. Its market cap has increased by 218.21% in one year.
Market Cap
2.68B
Enterprise Value
2.64B
1-Year Change
218.21%
Ranking
Category
Stock Price
$38.97
ChartMarket Cap Chart
Since March 15, 2017, uniQure's market cap has increased from $161.10M to $2.68B, an increase of 1,563.16%. That is a compound annual growth rate of 35.01%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 2.46B | 64.88% |
| Dec 31, 2025 | 1.49B | 73.16% |
| Dec 31, 2024 | 860.80M | 165.93% |
| Dec 29, 2023 | 323.70M | -69.50% |
| Dec 30, 2022 | 1.06B | 10.73% |
| Dec 31, 2021 | 958.50M | -40.38% |
| Dec 31, 2020 | 1.61B | -48.57% |
| Dec 31, 2019 | 3.13B | 190.93% |
| Dec 31, 2018 | 1.07B | 78.06% |
| Dec 29, 2017 | 603.40M | 274.55% |
| Mar 15, 2017 | 161.10M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MBX Biosciences | 2.95B |
| Disc Medicine | 2.83B |
| Celldex Therapeutics | 2.77B |
| AtaiBeckley | 2.66B |
| Ultragenyx Pharmaceutical | 2.64B |
| Kodiak Sciences | 2.59B |
| Vera Therapeutics | 2.54B |
| Tarsus Pharmaceuticals | 2.52B |